1. Home
  2. WNEB vs STXS Comparison

WNEB vs STXS Comparison

Compare WNEB & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WNEB
  • STXS
  • Stock Information
  • Founded
  • WNEB 1853
  • STXS 1990
  • Country
  • WNEB United States
  • STXS United States
  • Employees
  • WNEB N/A
  • STXS 139
  • Industry
  • WNEB Savings Institutions
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • WNEB Finance
  • STXS Health Care
  • Exchange
  • WNEB Nasdaq
  • STXS Nasdaq
  • Market Cap
  • WNEB 195.7M
  • STXS 254.1M
  • IPO Year
  • WNEB N/A
  • STXS 2004
  • Fundamental
  • Price
  • WNEB $12.44
  • STXS $2.79
  • Analyst Decision
  • WNEB Buy
  • STXS
  • Analyst Count
  • WNEB 2
  • STXS 0
  • Target Price
  • WNEB $11.00
  • STXS N/A
  • AVG Volume (30 Days)
  • WNEB 62.1K
  • STXS 343.7K
  • Earning Date
  • WNEB 10-22-2025
  • STXS 11-10-2025
  • Dividend Yield
  • WNEB 2.31%
  • STXS N/A
  • EPS Growth
  • WNEB N/A
  • STXS N/A
  • EPS
  • WNEB 0.59
  • STXS N/A
  • Revenue
  • WNEB $76,036,000.00
  • STXS $31,806,000.00
  • Revenue This Year
  • WNEB N/A
  • STXS $30.92
  • Revenue Next Year
  • WNEB $7.36
  • STXS $43.27
  • P/E Ratio
  • WNEB $20.56
  • STXS N/A
  • Revenue Growth
  • WNEB 2.15
  • STXS 33.94
  • 52 Week Low
  • WNEB $7.63
  • STXS $1.54
  • 52 Week High
  • WNEB $12.70
  • STXS $3.05
  • Technical
  • Relative Strength Index (RSI)
  • WNEB 63.09
  • STXS 53.51
  • Support Level
  • WNEB $11.90
  • STXS $2.73
  • Resistance Level
  • WNEB $12.70
  • STXS $2.94
  • Average True Range (ATR)
  • WNEB 0.23
  • STXS 0.09
  • MACD
  • WNEB -0.08
  • STXS -0.02
  • Stochastic Oscillator
  • WNEB 67.50
  • STXS 48.15

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: